Invitae

Website:invitae.com
Location:San Francisco, CA United States
Revenue:$147.7M
Industry:Biotech
Founded:2010
Lead Investor(s):J.P. Morgan Securities LLC, Cowen and Company, LLC
Press

Current Growjo Ranking

City Ranking

Industry Ranking

State Ranking

Growjo 10k Ranking

Invitae is a genetic information company whose mission is to bring genetic information into routine medical practice to improve the quality of healthcare for billions of people. Specializing in genetic diagnostics for hereditary disorders, Invitae is aggregating the world's genetic tests into a single service with better quality, faster turnaround time, and a lower price than most single-gene diagnostic tests today. Choose from our curated panels or design your own test for the same low price. Today, we are reinventing genetic testing by lowering the barriers for clinicians and patients to obtain diagnostic genetic information. Together we can improve healthcare for billions of people.

keywords:Biotechnology,E-Commerce,Healthcare,Medical Diagnostics,Pharmaceuticals

747

Number of Employees

$147.7M

Revenue (est)

128

Current Jobs

27%

Employee Growth %

$195.5M

Total Funding

N/A

Valuation

N/A

Accelerator

B2B

Type

Invitae News

6-Mar-19 - Invitae Announces Exercise in Full of Underwriters' Option to Purchase

SAN FRANCISCO, March 6, 2019 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA) today announced the exercise in full of the underwriters'

20-Mar-19 - Patterson-UTI Energy, Inc. (PTEN) and Invitae Corporation (NVTA

Looking at top Wall Street opinions, Patterson-UTI Energy, Inc. (NASDAQ: PTEN) has recently made its way into the research list of Goldman

21-Feb-19 - Invitae and Myriad Step Into Crowded Market with Noninvasive

This article has been updated with additional pricing information from Invitae. NEW YORK (GenomeWeb) – In an effort to broaden their

Invitae Funding

DateAmountRoundLead InvestorsReference
2013-12-11$40.0MEArticle
2014-10-14$120.0MFMultipleArticle
2016-11-18$44.0MUndisclosedJ.P. Morgan Securities LLCArticle
2018-02-28$40.0MUndisclosedOxford Finance, LLCArticle
2018-03-27$57.5MUndisclosedJ.P. Morgan Securities LLCArticle
2019-03-05$143.8MUndisclosedJ.P. Morgan Securities LLCArticle

Invitae Executive Hires

DateNameTitleReference
2017-01-10Sean GeorgeCEOArticle
2017-05-26Shelly GuyerCFOArticle

Invitae Acquisitions

DateCompany NameAmountNotesReference
2017-01-09AltaVoice (formerly PatientCrossroadsStock Deal -Not CompleteArticle
2017-06-13CancerGeneConnectArticle
2017-08-01Good Start Genetics, IncArticle
2017-11-16CombiMatrix CorporationArticle